Delivery Order SPE2DB24D1034-SPE2DB24FVYJ1
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $5.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. The $35,124.00 contract has a performance period ending on January 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was not...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,512.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award has a potential value of $35,124.00 and a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received numerous...
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $74,097.05 award is for the supply of 4563225576 ! MENQUADFI VIAL 0.5ML, a pharmaceutical product. The delivery order has a completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received...
- This is a $1,209.78 firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4564485987 MENQUADFI VIAL 0.5ML medical products. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical and medical supplies to the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The firm fixed price delivery order has a potential value of $2,809.92 and a completion date of December 22, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides a range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,435.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceuticals. The order is set to be completed by December 7, 2023 and was awarded on December 6, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $35,124.00 contract is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of January 17, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous DLA contracts to supply pharmaceuticals, medical supplies, and related distribution services to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order, valued at $77,311.05, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to support military treatment programs and facilities. There is no set-aside designation associated with this contract. Amerisourcebergen Drug Corp serves as a prime contractor...